Novel Eye Drop Delivery Aid Improves Outcomes and Satisfaction

Area of Science:

• Ophthalmology
• Medical Devices
• Glaucoma Treatment

Background:

• Glaucoma management relies on topical eye drops.
• Patients often face challenges with traditional eye drop self-administration.
• Difficulty in application can lead to poor adherence and treatment efficacy.

Purpose of the Study:

• To compare the efficacy and patient satisfaction of a novel nose-pivoted drop delivery device (NPDD) against traditional eye drop delivery methods.
• To assess the impact of the NPDD on accurate drop placement, bottle tip contact, and medication waste in glaucoma patients.

Main Methods:

• A repeated-measures case series involving 50 glaucoma subjects with self-administration difficulties.
• Comparison of NPDD versus traditional delivery (baseline and post-teaching) using ease-of-use ratings and satisfaction surveys.
• Objective assessment of eye drop delivery via digital video analysis, recording accurate placement, bottle tip contact, and number of drops dispensed.

Main Results:

• 94% of subjects preferred the NPDD, with significantly higher ease-of-use scores (8.9 vs. 6.7-7.0, P < 0.001).
• The NPDD significantly reduced bottle tip ocular/periocular contact (10 eyes vs. 33/25 eyes, P < 0.009) and medication waste (1.7 drops vs. 2.2-2.4 drops, P < 0.017).
• Primary success (accurate placement, no contact) increased with NPDD (86%) compared to traditional methods (66-70%, P < 0.005).

Conclusions:

• The nose-pivoted drop delivery device (NPDD) offers a superior alternative to traditional eye drop delivery for glaucoma patients.
• NPDD enhances patient preference, improves delivery success rates, and minimizes ocular surface contamination and drug wastage.
• This device holds significant potential for improving adherence and outcomes in glaucoma therapy.